Kymera Therapeutics
KYMR
#2683
Rank
NZ$10.81 B
Marketcap
NZ$150.26
Share price
-2.73%
Change (1 day)
93.52%
Change (1 year)

Market capitalization of Kymera Therapeutics (KYMR)

Market cap: NZ$10.81 Billion

As of December 2025 Kymera Therapeutics has a market cap of NZ$10.81 Billion. This makes Kymera Therapeutics the world's 2683th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Kymera Therapeutics from 2020 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$10.81 B134.7%
2024NZ$4.60 B106.19%
2023NZ$2.23 B3.57%
2022NZ$2.15 B-54.84%
2021NZ$4.77 B25.03%
2020NZ$3.82 B

End of Day market cap according to different sources

On Dec 10th, 2025 the market cap of Kymera Therapeutics was reported to be:

NZ$11.11 Billion
by Nasdaq info icon info icon
NZ$11.11 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ$1.64 B-84.80%๐Ÿ‡บ๐Ÿ‡ธ USA